SMTL ID : 6urc.1 (2 other biounits)

Crystal structure of IRE1a in complex with compound 18

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

2 x QFV: 2-chloro-N-(6-methyl-5-{[3-(2-{[(3S)-piperidin-3-yl]amino}pyrimidin-4-yl)pyridin-2-yl]oxy}naphthalen-1-yl)benzene-1-sulfonamide(Non-covalent)

QFV.1: 22 residues within 4Å: Chain A: L.31, G.32, V.40, A.51, K.53, E.66, V.67, L.70, I.80, Y.82, I.94, I.96, E.97, L.98, C.99, A.100, A.101, E.105, L.149, S.164, D.165, F.166 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:L.31, A:A.51, A:K.53, A:V.67, A:L.70, A:I.80, A:Y.82, A:I.94, A:I.94, A:I.96, A:L.149, A:D.165 Hydrogen bonds: A:K.53, A:C.99, A:C.99, A:E.105, A:D.165, A:F.166 Water bridges: A:D.165, A:G.167 QFV.3: 22 residues within 4Å: Chain B: L.31, G.32, V.40, A.51, K.53, E.66, V.67, I.80, Y.82, I.94, I.96, E.97, L.98, C.99, A.100, A.101, E.105, H.146, L.149, S.164, D.165, F.166 18 PLIP interactions: 18 interactions with chain B Hydrophobic interactions: B:L.31, B:A.51, B:K.53, B:V.67, B:I.80, B:Y.82, B:I.94, B:I.94, B:I.96, B:L.149, B:D.165 Hydrogen bonds: B:K.53, B:C.99, B:C.99, B:E.105, B:D.165, B:F.166 Water bridges: B:K.53

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 9 residues within 4Å: Chain A: F.45, D.46, R.48, R.81, F.83 Chain B: E.75, R.81, Y.82, F.83 4 PLIP interactions: 3 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:E.75, A:F.83 Water bridges: B:E.75, B:Y.82

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Harnoss, J.M. et al., Disruption of IRE1 alpha through its kinase domain attenuates multiple myeloma. Proc. Natl. Acad. Sci. U.S.A. (2019)

Release Date

2019-11-06

Peptides

Serine/threonine-protein kinase/endoribonuclease IRE1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Serine/threonine-protein kinase/endoribonuclease IRE1

Related Entries With Identical Sequence